Over the past few years, Zoloft has been linked to patient reports of increased depression and suicidal behavior, the number of zoloft lawsuits has skyrocketed over the past few years. Several drug advisory committees including the Food and Drug Administration (FDA) and the Psychopharmacological Drugs Advisory Committee (PDAC) continue to investigate these claims.
Pfizer began marketing the Zoloft in 1992. Today, Zoloft generates $2 billion dollars in annual sales and is among Pfizer’s top selling drugs. It is prescribed to both adult and pediatric patients and marketed as a versatile drug that can treat six mood and anxiety disorders, psychiatric and non-psychiatric disorders.
Since the early 1990s numerous world class experts have warned about the role of SSRI-induced akathisia in violence and suicide. On March 19, 1996, the FDA wrote to Pfizer stating: “We note that there appears to be an increased frequency of reports of suicidality in the pediatric/adolescent patients exposed to Sertraline [Zoloft] compared to either placebo or Sertraline-treated OCD patients. If this is in fact the case what would be a plausible explanation?” Birth Defect Lawsuit Zoloft.